Dr Stephen Ng

Dr Stephen Ng is a Senior Consultant in the Oculoplastic Department of the Singapore National Eye Centre (SNEC).  He obtained his medical degree from the University of Otago in New Zealand in 1987. In 1997 he gained Fellowship of the Royal Australian & New Zealand College of Ophthalmologists (RANZCO). From 1997 to 2000, he undertook post-fellowship training in England including a fellowship in oculoplastic, lacrimal & orbital surgery at the Manchester Royal Eye Hospital. In 2000, Dr Ng was appointed as a Consultant Ophthalmic, Oculoplastic & Orbital Surgeon at Waikato Hospital, New Zealand.  He was awarded the Fellowship of the Australian & New Zealand Society of Oculoplastic & Reconstructive Surgeons in 2002. In 2002, he was also appointed as an Honorary Senior Lecturer at the University of Auckland.  He has twice been awarded the RANZCO “Award for Excellence in Training”.

To date, Dr Ng’s academic contributions include co-authoring 23 peer-reviewed scientific papers and two book chapters.  He is currently involved in research on eyelid reconstruction, periorbital infections and the use of artificial Intelligence in oculoplastics.

• FRANZCO (1997)·   
• MBChB (Otago) (1987)

• Honorary Senior Lecturer University of Auckland, (2002-present)·   
• Fellow of the Australian & New Zealand Society of Oculoplastic & Reconstructive Surgeons, (2002-present)·      
• Acting Chair & Board Member, Hospice Waikato (2021-2024)·      
• Clinical Leader New Zealand Ministry of Health Ophthalmology Expert Advisory Group, (2017-2019)·      
• Chair of RANZCO New Zealand Branch,(2015-2017)·      
• RANZCO NZ Branch Executive Committee Member,(2009-2019)·      
• Clinical Director Eye Department, Waikato Hospital,(2002-2024 & (2014-2016)·      
• Chair of the Save Sight Society of New Zealand, (2012-2015)
• Director of the Save Sight Society of New Zealand,( 2008-2018)·      
• Section Editor for the journal “Clinical & Experimental Ophthalmology”,(2008-2018)

• RANZCO “Award for Excellence in Training”, (2010 & 2018)

1. Ankyloblepharon-ectodermal dysplasia-clefting syndrome. Surgical and medical management in an infant with bilateral corneal perforations.  Hossain RR, Ng SGJ, Chong CF, Botha VE, Ferguson R, McKelvie J. Indian J Ophthalmol 2022;70:2633-5. 
2. Extreme Cancer of the Periorbital Region” Ng SGJ, Klaassen MF, Brown E. Atlas of Extreme Facial Cancer 2022 (pp. 215-274). Springer, Cham. 
3. Hughes flap in the management of lower lid retraction. Juniat V, Ryan T, O ‘Rourke M, Ng SGJ, O’Donnell B, McNab AA, Selva D. Orbit. 2021 Dec 20:1-6.
4. Neuronal Regeneration Potential of Facial Nerve for Compound Wound in an Elderly Patient.” Cox S, Hossain R, Ng SGJ, Mani M & Tan EK.  Innovations Tissue Eng Regen Med. 1(4) ITERM.000519.2021. 
5. Cataract surgery in New Zealand: access to surgery, surgical intervention rates and visual acuity. Chilibeck C, Mathan JJ, Ng SGJ, McKelvie J. N Z Med J. 2020 Oct 30;133(1524):40-49. 
6. Periorbital Desmoplastic Squamous Cell Carcinoma.  Botha, V, Chong SW, KTK, Salmon, PJM, El-Khayat, R, Chan, Y, Selva, D, Ng SGJ. Orbit 2019; 38:3, 240-243. 
7. Cicatricial ectropion surgery: prospective study of long-term symptom control, patient satisfaction and anatomical success.  McKelvie J, Papchenko T, Carroll S, Ng SGJ. Clinical & Experimental Ophthalmology 2018; 46:1002-7 
8. Eyelid reconstruction using the ‘Hughes’ tarsoconjunctival advancement flap: Long term outcomes in 122 consecutive cases over a 13-year period.  McKelvie J, Ferguson R, Ng SGJ. Orbit 2017; Aug;36(4):228-233 
9. A practical decision-tree model to predict complexity of reconstructive surgery after periocular basal cell carcinoma excision. Tan E, Lin F, Sheck L, Salmon P & Ng SGJ. Journal of the European Academy of Dermatology & Venereology 2017. Apr;31(4):717-723. 
10. Growth of Periocular Basal Cell Carcinoma.  Tan E, F.P.Y. Lin FPY, L.H.N. Sheck LHN, Salmon PJ and Ng SGJ.  British Journal of Dermatology. 2015; 172 (4): 1002–1007..
11. Orbital Adherence with Titanium Mesh Floor Implants: a review of 10 cases. Kersey TL, Ng SGJ, Rosser P, Sloan B, Hart R. Orbit 2013; 32: 8–11 
12. Primary orbital extraskeletal osteosarcoma.  Fan JC, Lamont DL, Greenbaum AR, Ng  SGJ.  Orbit, 2011; 30(6), 297–299. 
13. Prolene frontalis suspension in paediatric ptosis. Chow K, Deva N, Ng SGJ.  Eye 2011; 25: 735-739. 
14. Outcomes of orbital blowout fracture surgery in children and adolescents.  Carroll SC, Ng SGJ. British Journal of Ophthalmology 2010; 94:736-739.
15. Grzybowski’s generalized eruptive keratoacanthoma: remission with cyclophosphamide.  Oakley A,  Ng SGJ.  Australasian Journal of Dermatology 2005; 46:118-125. 
16. Primary Banked Scleral Patch Graft in the Prevention of Exposure of Hydroxyapatite Orbital Implants.  Inkster CF, Ng SGJ, Leatherbarrow B.  Ophthalmology 2002;109: 389-392. 
17. Medpor Porous Polyethylene Implants in Orbital Blowout Fracture Repair.  Ng SGJ, Madill SA, Inkster CF, Leatherbarrow B.  Eye 2001; 15:578-582. 
18. Necrotizing Orbital Cellulitis.  Ng SGJ, Nazir R, Sabhudi CPK, Laitt RD, Maloof  A, Leatherbarrow  B.  Eye 2001;15: 173-7. 
19. The Rhomboid Flap in Medial Canthal Reconstruction.  Ng SGJ, Inkster CF, Leatherbarrow B.  British Journal of Ophthalmology 2001; 85:556-559. 
20. The Maximal Hughes Procedure.  Maloof A, Ng SGJ, Leatherbarrow B.  Ophthalmic Plastic & Reconstructive Surgery 2001;2:96-102.